ERIN WILLIAMSON: Open Payments
NPI 1487884995 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,141 in 92 payments from 17 companies in 2025. Trend: 2023 $2,060 · 2024 $2,176 · 2025 $3,141
Food & beverage: $2,238Travel & lodging: $903
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 4 | $1,179 |
| ABBVIE INC. | 35 | $765 |
| GENZYME CORPORATION | 6 | $169 |
| PFIZER INC. | 8 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $141 |
| Madrigal Pharmaceuticals | 4 | $107 |
| Aimmune Therapeutics, Inc. | 4 | $98 |
| Lilly USA, LLC | 4 | $97 |
| Janssen Biotech, Inc. | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $84 |
Products named: CREON, DUPIXENT, LINZESS, RINVOQ, REZDIFFRA, ZENPEP, OMVOH, VELSIPITY.
Industry payments across OK — which companies pay providers there.
